The Online Investor
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Wed., Dec. 11, 4:09 PM

Slide #77. Roche Poseida Therapeutics, Inc.

Acquirer: Roche
Acquiree: Poseida Therapeutics, Inc. (NASDAQ:PSTX)
Details: Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has entered into a definitive merger agreement to acquire Poseida Therapeutics, Inc. ("Poseida", NASDAQ:PSTX), a public clinical-stage biopharmaceutical company pioneering donor-derived CAR-T cell therapies. Based in San Diego, California, Poseida's R&D portfolio includes pre-clinical and clinical-stage off-the-shelf (also referred to as allogeneic) CAR-T therapies across several therapeutic areas including haematological malignancies, solid tumours, and autoimmune disease, as well as manufacturing capabilities and technology platforms.



Open the PSTX Page at The Online Investor »

Company Name:  Poseida Therapeutics Inc
Website:  www.poseida.com
Sector:  Biotechnology
Number of ETFs Holding PSTX:  35
Total Market Value Held by ETFs:  $80.09M
Total Market Capitalization:  $920.00M
% of Market Cap. Held by ETFs:  8.71%
 

Open the PSTX Page at The Online Investor (in a new window) »

December 11, 2024    4:09 PM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree PSTX Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)

Analysts' Target Price:
PSTX Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.